By vgreene, 28 October, 2021 FDA MedWatch Hydroxychloroquine or Chloroquine for COVID 19 Drug Safety Communication FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems see FDA alert
By vgreene, 28 October, 2021 Proposed mechanism inhibits viral entry and replication via intracellular alkalinization interferes w maturation of viral particles through impaired glycosylation indirect immunomodulatory effects
